MKKGY
Price
$26.07
Change
-$0.50 (-1.88%)
Updated
Jul 3 closing price
Capitalization
76.59B
32 days until earnings call
ZTS
Price
$159.18
Change
+$0.10 (+0.06%)
Updated
Jul 3 closing price
Capitalization
77.48B
30 days until earnings call
Interact to see
Advertisement

MKKGY vs ZTS

Header iconMKKGY vs ZTS Comparison
Open Charts MKKGY vs ZTSBanner chart's image
Merck KGaA
Price$26.07
Change-$0.50 (-1.88%)
Volume$50.65K
Capitalization76.59B
ZOETIS
Price$159.18
Change+$0.10 (+0.06%)
Volume$1.38M
Capitalization77.48B
MKKGY vs ZTS Comparison Chart in %
Loading...
MKKGY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MKKGY vs. ZTS commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MKKGY is a Buy and ZTS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (MKKGY: $26.08 vs. ZTS: $159.18)
Brand notoriety: MKKGY: Not notable vs. ZTS: Notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: MKKGY: 36% vs. ZTS: 46%
Market capitalization -- MKKGY: $76.59B vs. ZTS: $77.48B
MKKGY [@Pharmaceuticals: Other] is valued at $76.59B. ZTS’s [@Pharmaceuticals: Other] market capitalization is $77.48B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.8B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MKKGY’s FA Score shows that 1 FA rating(s) are green whileZTS’s FA Score has 1 green FA rating(s).

  • MKKGY’s FA Score: 1 green, 4 red.
  • ZTS’s FA Score: 1 green, 4 red.
According to our system of comparison, ZTS is a better buy in the long-term than MKKGY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MKKGY’s TA Score shows that 4 TA indicator(s) are bullish while ZTS’s TA Score has 3 bullish TA indicator(s).

  • MKKGY’s TA Score: 4 bullish, 3 bearish.
  • ZTS’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, MKKGY is a better buy in the short-term than ZTS.

Price Growth

MKKGY (@Pharmaceuticals: Other) experienced а -0.30% price change this week, while ZTS (@Pharmaceuticals: Other) price change was +2.18% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.13%. For the same industry, the average monthly price growth was +3.08%, and the average quarterly price growth was +93.03%.

Reported Earning Dates

MKKGY is expected to report earnings on Nov 13, 2025.

ZTS is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+2.13% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ZTS($77.5B) and MKKGY($76.6B) have the same market capitalization . ZTS has higher P/E ratio than MKKGY: ZTS (32.94) vs MKKGY (21.41). ZTS YTD gains are higher at: -1.676 vs. MKKGY (-7.296). MKKGY has higher annual earnings (EBITDA): 6.45B vs. ZTS (3.67B). ZTS has more cash in the bank: 2.04B vs. MKKGY (1.72B). ZTS has less debt than MKKGY: ZTS (6.76B) vs MKKGY (10.6B). MKKGY has higher revenues than ZTS: MKKGY (22.3B) vs ZTS (8.54B).
MKKGYZTSMKKGY / ZTS
Capitalization76.6B77.5B99%
EBITDA6.45B3.67B176%
Gain YTD-7.296-1.676435%
P/E Ratio21.4132.9465%
Revenue22.3B8.54B261%
Total Cash1.72B2.04B84%
Total Debt10.6B6.76B157%
FUNDAMENTALS RATINGS
MKKGY vs ZTS: Fundamental Ratings
MKKGY
ZTS
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
28
Undervalued
66
Overvalued
PROFIT vs RISK RATING
1..100
8580
SMR RATING
1..100
6919
PRICE GROWTH RATING
1..100
6161
P/E GROWTH RATING
1..100
8774
SEASONALITY SCORE
1..100
9585

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MKKGY's Valuation (28) in the null industry is somewhat better than the same rating for ZTS (66) in the Pharmaceuticals Generic industry. This means that MKKGY’s stock grew somewhat faster than ZTS’s over the last 12 months.

ZTS's Profit vs Risk Rating (80) in the Pharmaceuticals Generic industry is in the same range as MKKGY (85) in the null industry. This means that ZTS’s stock grew similarly to MKKGY’s over the last 12 months.

ZTS's SMR Rating (19) in the Pharmaceuticals Generic industry is somewhat better than the same rating for MKKGY (69) in the null industry. This means that ZTS’s stock grew somewhat faster than MKKGY’s over the last 12 months.

ZTS's Price Growth Rating (61) in the Pharmaceuticals Generic industry is in the same range as MKKGY (61) in the null industry. This means that ZTS’s stock grew similarly to MKKGY’s over the last 12 months.

ZTS's P/E Growth Rating (74) in the Pharmaceuticals Generic industry is in the same range as MKKGY (87) in the null industry. This means that ZTS’s stock grew similarly to MKKGY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MKKGYZTS
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 4 days ago
57%
Bearish Trend 4 days ago
63%
Momentum
ODDS (%)
Bullish Trend 4 days ago
69%
Bullish Trend 4 days ago
59%
MACD
ODDS (%)
Bullish Trend 4 days ago
61%
Bearish Trend 4 days ago
53%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
60%
Bullish Trend 4 days ago
61%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
61%
Bearish Trend 4 days ago
58%
Advances
ODDS (%)
Bullish Trend 5 days ago
62%
Bullish Trend 14 days ago
59%
Declines
ODDS (%)
Bearish Trend 19 days ago
56%
Bearish Trend 11 days ago
55%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
72%
Bullish Trend 4 days ago
68%
Aroon
ODDS (%)
N/A
Bearish Trend 4 days ago
64%
View a ticker or compare two or three
Interact to see
Advertisement
MKKGY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
BUFR32.030.14
+0.44%
FT Vest Laddered Buffer ETF
BJUN43.990.10
+0.24%
Innovator U.S. Equity Buffer ETF™ - June
IWFL46.90N/A
N/A
ETRACS 2x Leveraged US Gr Fctr TR ETN
LFAI125.51N/A
N/A
LifeX 2050 Longevity Income ETF
ILTB49.06-0.14
-0.28%
iShares Core 10+ Year USD Bond ETF

MKKGY and

Correlation & Price change

A.I.dvisor indicates that over the last year, MKKGY has been loosely correlated with MKGAF. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if MKKGY jumps, then MKGAF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MKKGY
1D Price
Change %
MKKGY100%
-1.90%
MKGAF - MKKGY
49%
Loosely correlated
+0.12%
AMPH - MKKGY
25%
Poorly correlated
-1.61%
ZTS - MKKGY
25%
Poorly correlated
+0.06%
SUPN - MKKGY
25%
Poorly correlated
-0.28%
INDV - MKKGY
24%
Poorly correlated
+0.06%
More

ZTS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZTS has been loosely correlated with VTRS. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ZTS jumps, then VTRS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZTS
1D Price
Change %
ZTS100%
+0.06%
VTRS - ZTS
43%
Loosely correlated
-0.21%
PAHC - ZTS
41%
Loosely correlated
+0.21%
AMRX - ZTS
38%
Loosely correlated
+0.60%
ELAN - ZTS
38%
Loosely correlated
-0.54%
PBH - ZTS
35%
Loosely correlated
-0.25%
More